期刊文献+

miR-196b通过LRIG2调控宫颈癌细胞增殖和凋亡生物学特性的分子机制

Molecular mechanism of miR-196b regulating the biological characteristics of proliferation and apoptosis in cervical cancer cells through LRIG2
下载PDF
导出
摘要 目的:探讨miR-196b对宫颈癌细胞增殖和凋亡的影响以及潜在的作用机制。方法:运用实时定量聚合酶链式反应(qRT-PCR)检测宫颈癌细胞HeLa、SiHa、C33a、Caski和正常宫颈细胞株Ect1/E6E7中miR-196b和LRIG2 mRNA的表达水平;将宫颈癌SiHa细胞分为miR-con组(转染miR-con)、miR-196b组(转染miR-196b mimics)、anti-miR-con组(转染anti-miR-con)、anti-miR-196b组(转染miR-196b inhibitor)、miR-196b+si-con组(共转染miR-196b和si-con)、miR-196b+si-LRIG2组(共转染miR-196b和si-LRIG2)、miR-con+WT-LRIG2组(共转染miR-con和WT-LRIG2)、miR-con+MUT-LRIG2组(共转染miR-con和MUT-LRIG2)、miR-196b+WT-LRIG2组(共转染miR-196b和WT-LRIG2)、miR-196b+MUT-LRIG2组(共转染miR-196b和MUT-LRIG2)。采用MTT法检测细胞增殖;流式细胞术检测细胞凋亡;Western Blot检测蛋白表达;双荧光素酶报告实验检测荧光活性。结果:相较于正常宫颈细胞株Ect1/E6E7,宫颈癌细胞HeLa、SiHa、C33a、Caski中miR-196b的表达水平显著升高,LRIG2的表达水平显著降低(P<0.05);干扰miR-196b可抑制SiHa细胞增殖促进细胞凋亡;抑制Bcl-2、CDK4和Cyclin D1蛋白的表达,促进Bax、Caspase-3蛋白的表达。miR-196b靶向调控LRIG2的表达。抑制LRIG2表达能逆转干扰miR-196b对SiHa细胞的抑制增殖、促进凋亡的作用以及对AKT信号通路中PI3K、p-AKT、p-mTOR蛋白表达的抑制作用。结论:miR-196b可抑制宫颈癌细胞增殖,促进其凋亡,其机制可能与LRIG2及AKT信号通路有关,将可为宫颈癌的预防和治疗提供新靶点。 Objective:To investigate the effects of miR-196b on proliferation and apoptosis of cervical cancer cells and its potential mechanism.Methods:Expressions of of miR-196b and LRIG2 mRNA in cervical cancer cells HeLa,SiHa,C33a,Caski and normal cervical cell line Ect1/E6E7 were detected by real-time quantitative polymerase chain reaction(qRT-PCR).Cervical cancer SiHa cells were divided into miR-con group(transfected miR-con),miR-196b group(transfected miR-196b mimics),anti-miR-con group(transfected anti-miR-con),anti-miR-196b group(transfected anti-miR-196b),miR-196b+si-con group(co-transfected miR-196b and si-con),miR-196b+si-LRIG2 group(co-transfected miR-196b and si-LRIG2),miR-con+WT-LRIG2 group(co-transfected miR-con and WT-LRIG2),miR-con+MUT-LRIG2 group(co-transfected miR-con and MUT-LRIG2),miR-196b+WT-LRIG2(co-transfected miR-196b and WT-LRIG2),miR-196b+MUT-LRIG2 group(co-transfected miR-196b and MUT-LRIG2).Cell proliferation was detected by MTT assay;apoptosis was detected by flow cytometry;protein expression was detected by Western Blot;fluorescence activity was detected by double luciferase reporter assay.Results:Compared with the normal cervical cell line Ect1/E6E7,the expression levels of miR-196b in cervical cancer cells HeLa,SiHa,C33a and Caski were significantly increased,and the expression level of LRIG2 was significantly decreased(P<0.05);interference with miR-196b inhibited SiHa cell proliferation and promotes apoptosis;inhibited the expressions of Bcl-2,CDK4 and Cyclin D1 proteins,and promoted the expression of Bax and Caspase-3 proteins.miR-196b targets and regulate the expression of LRIG2.Overexpression of LRIG2 reversed the inhibitory effect of miR-1.
作者 李娜 宋泓 王茜 Li Na;Song Hong;Wang Qian(Department of Gynecology,Central Hospital of Chenzhou first people's Hospital,Chenzhou 423000,Hunan)
出处 《现代科学仪器》 2021年第4期92-97,共6页 Modern Scientific Instruments
  • 相关文献

参考文献7

二级参考文献54

  • 1万崇华,孟琼,汤学良,张灿珍,罗家洪,张晓磐.癌症患者生命质量测定量表FACT-G中文版评介[J].实用肿瘤杂志,2006,21(1):77-80. 被引量:400
  • 2叶章群,严泽军,杨为民,郭东升.LRIG1基因对膀胱癌细胞侵袭力的影响[J].中华外科杂志,2007,45(4):258-261. 被引量:13
  • 3曾令成,欧一博,雷霆,郭东生.LRIG1在脑膜瘤中的表达及与其生物学行为的关系[J].中国临床神经外科杂志,2007,12(10):601-604. 被引量:7
  • 4Eisenstat DD,Gibson SB. RIGging functional outcomes in glioma cells:new insights into LRIG proteins in malignant gliomas[J]. Cancer Biol Ther,2009,8(11) :1024- 1026.
  • 5Nilsson J, Starefeidt A, Henriksson R, et al. LRIG1 pro- tein in human cells and tissues[J]. Cell Tissue Res,2003, 312(1):65-71.
  • 6Tanemura A,Nagasawa T,Inui S, et al. LRJG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin:immunohistochemical analysis for 38 cases[J]. Dermatal Surg,2005,31(4) :423-430.
  • 7Miller JK, Shattuck DL, Ingalla EQ, et al. Suppression of the negative regulator LRIG1 contributes to ErbB2 over- expression in breast cancer[J]. Cancer Res, 2008,68(20) : 8286-8294.
  • 8Wu X, Hedman H,Bergqvist M, et al. Expression of EG- FR and LRIG proteins in oesophageal carcinoma with em- phasis on patient survival and cellular chemosensitivity [J]. Acta Oncol,2012,51(1) :69-76.
  • 9Krig SR,Frietze S,Simion C,et al. Lrigl is an estrogen- regulated growth suppressor and correlates with longer relapse-free survival in ERa-positive breast cancer[J]. Mol Cancer Res,2011,9(10) :1406-1417.
  • 10Lingdstrom AK, Ekman K, Stendahl U, et al. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis,other tumour markers, sex steroid hormones, and smoking[J]. Int J Gynecol Cancer, 2008,18(2) : 312- 317.

共引文献205

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部